Attila Nagy

Hypothalamic Hormones and Cancer

Andrew V. Schally, Attila Nagy, Magdolna Kovács et al. · Frontiers in Neuroendocrinology · 2001 · 253 citations · Full text

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

Cornelis J.A. Punt, Attila Nagy, Jean-Yves Douillard et al. · The Lancet · 2002 · 213 citations

Oncology, Gastrointestinal Oncology, Medicine +9

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Attila Nagy, Andrew V. Schally, Patricia Armatis et al. · Proceedings of the National Academy of Sciences · 1996 · 203 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Pharmaceutical Chemistry +16

Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen.

Samuel R. Denmeade, Attila Nagy, Jin Gao et al. · PubMed · 1998 · 147 citations

New Approaches, Peptide Therapeutics, Prostate-specific Antigen +16

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

Attila Nagy, Andrew V. Schally, Gábor Halmos et al. · Proceedings of the National Academy of Sciences · 1998 · 143 citations · Full text